Lexeo Therapeutics Inc. C... (LXEO)
NASDAQ: LXEO
· Real-Time Price · USD
4.71
-0.08 (-1.67%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.21%
After-hours: Aug 15, 2025, 05:36 PM EDT
Lexeo Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -32.66M | -25.92M | -29.49M | -21.24M | -21.68M | -14.19M | -20.11M | -13.44M | -18.66M | -14.58M | -17.05M | -15.14M | -12.5M |
Depreciation & Amortization | 72K | 521K | -743K | 496K | 476K | 490K | 460K | 446K | 447K | 445K | 342K | 351.3K | 6.7K |
Stock-Based Compensation | 3.7M | 3.51M | 3.79M | 2.85M | 2.33M | 804K | 873K | 969K | 397K | 521K | 431K | n/a | n/a |
Other Working Capital | 1.59M | -4.37M | -4.47M | -3.31M | 3.37M | -1.74M | 4.26M | 743K | -1.6M | -1.79M | 4.49M | 2.36M | -2.78M |
Other Non-Cash Items | 12K | -23K | 10.39M | n/a | n/a | 258K | 272K | n/a | n/a | n/a | n/a | 554.11K | 274.72K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 6.73M | -6.41M | -1.75M | -2.26M | 4.01M | -1.35M | 4.55M | -1.17M | -561K | -3.02M | 4.49M | 3.19M | -2.87M |
Operating Cash Flow | -21.72M | -28.33M | -17.81M | -20.15M | -14.87M | -13.98M | -13.95M | -13.19M | -18.37M | -16.63M | -11.79M | -11.05M | -15.09M |
Capital Expenditures | n/a | 13K | -70K | -218K | -193K | -73K | -53K | -39K | n/a | -107K | -400K | -220.38K | -173.63K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 15.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -93.58M | -13K | -5K | -8K | n/a | -50K | n/a | n/a | -82K | -44K | n/a | n/a |
Investing Cash Flow | 15.6M | -93.58M | -83K | -218K | -193K | -73K | -53K | -39K | n/a | -107K | -400K | -220.38K | -173.63K |
Debt Repayment | -159K | -116K | -111K | -74K | -109K | -105K | 3.89M | -103K | -110K | -108K | -36K | n/a | n/a |
Common Stock Repurchased | n/a | -4K | 13K | -13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 23K | 39K | 419K | 10K | 100.18M | 19K | 9K | 12K | 28K | n/a | 49.01K | 255.99K |
Financial Cash Flow | 11K | -97K | -72K | 291K | 88.65M | 100.07M | 3.91M | -94K | -98K | -81K | -35K | 49.01K | 255.99K |
Net Cash Flow | -6.11M | -122.01M | -14.71M | -20.08M | 73.59M | 86.02M | -6.84M | -16.58M | -18.47M | -16.81M | -12.22M | -11.22M | -15.01M |
Free Cash Flow | -21.72M | -28.31M | -17.88M | -20.37M | -15.06M | -14.05M | -14M | -13.23M | -18.37M | -16.73M | -12.19M | -11.27M | -15.27M |